use of formulations comprising toltrazuril, or its physiologically acceptable salts, and an iron (iii) dextran compound

摘要

the present invention relates to the use of formulations containing triazines, such as toltrazuril, ponazuril or diclazuril, and iron compounds, for the preparation of drugs to control coccidial infections and iron deficiencies in animals and humans.